Government Funding. No government funding, facilities or resources of any government, international organization, university, college, other educational institution or research center was used in the development of the Company Products or Company Intellectual Property.
Government Funding. Neither the Company nor any Company Subsidiary has applied for or received any financial assistance from any supranational, national, local or foreign Governmental Authority.
Government Funding. Except as set forth in Section 3.8(u) of the Company Disclosure Letter, no government funding, facilities or resources of a university, college, other educational institution or research center or funding from third parties was used in the development of the Company Intellectual Property, and no Governmental Entity, university, college, other educational institution or research center has any claim or right in or to the Company Intellectual Property.
Government Funding. No government funding, facilities of a university, college, other educational institution or research center or development funding from third parties was used in the development of any Company Intellectual Property. To the Knowledge of the Company, no current or former employee, consultant or independent contractor of the Company, who was involved in, or who contributed to, the creation or development of any Company Intellectual Property, has performed services for the government, university, college, or other educational institution or research center during a period of time during which such employee, consultant or independent contractor was also performing services for the Company.
Government Funding. No government funding, facilities of a university or other educational institution or research centre or funding from third parties has been used in the development of the Software, and no such entity has any claim or right to or in the Software or any component thereof.
Government Funding. 7.1. FEET (Funded Early Education for Two Year Old’s) is available as a ‘Stretched offer’* only. No charges are applied unless a parent chooses to purchase additional sessions. Additional sessions must be agreed in advance and are charged at our prevailing fee schedule rates.
7.2. The 15HRS funding is available over a minimum of 2 full day’s attendance, and the 30HRS funding is available over a minimum of 3 full day’s attendance. Both are subject to our Monthly Voluntary Additional Service package charge, details of which are provided. Our Voluntary Additional Service Charge does not apply to funded 2YO’s. If you are unable to pay this charge and would like your child to opt out of these activities/ services, please contact us to discuss alternatives.
7.3. Parents are billed monthly and the fees for each month of the year are the same depending on the child’s particular attendance pattern. The 15 & 30 HRS funding is therefore taken into account evenly throughout the year (52 weeks) rather than merely over the 38 weeks in which it is paid to the Nursery. The effect of ‘stretching’ the 15HRS & 30HRS funding is taken into account when setting the fees.
7.4. Hours above and beyond the free 15HRS or 30 HRS are charged at our prevailing fee schedule rates. Parents who qualify for the 15HRS or 30HRS funding will have this amount reflected in their invoice.
7.5. Any private funding provided by your company will not be deducted from the invoice; it is up to you to account for this. Any fees not covered by a government or local authority subsidy are the parents' responsibility and are payable on the first of each month in advance. All subsidised payments must also be paid by the first of each month in advance.
Government Funding. None of the Assigned Patents were developed by, on behalf of, jointly with, or using grants or funding of any Governmental Entity, college, university, or educational institution.
Government Funding. Parents who qualify for Free Entitlement Hours will have an amount equivalent to this entitlement deducted from their invoice. Any fees over and above the Free Entitlement Hours, or other agreed subsidy, are the parents’ responsibility and are payable at the beginning of the month in arrears in accordance with this agreement. The compulsory daily charge for the morning snack is 50p, regardless of whether your child eats it or not. This is not covered by government funding for 3+ year olds and is payable by the parent. It is covered by government funding for 2-year olds, meaning no additional charge will be applied. Further information as to Government Funding and its application at Pre-School is set out in our Administration Policy (available on our website OR attached to this agreement at Annex 1) ILLNESS POLICY Please advise Pre-School prior to 8.30am if a child will not be attending due to illness. Please do not email that your child will not be attending. Parents agree that a child who is ill (e.g. fever, infection, diarrhoea, communicable disease or any other type of illness that may be passed onto others, with the exception of the common cold) will be kept at home to protect the well-being of staff and other children in our care. Parents further agree, should a child become ill during our care, that immediate arrangements will be made to remove the child from Pre-School. Children cannot return to Pre-School until they have been symptom free for 24 hours for a fever and 48 hours for sickness or diarrhoea. In some cases, a note from a doctor may be necessary. You agree that staff should seek any emergency medical advice or treatment deemed necessary for the wellbeing of your child whilst at Pre-School. Please refer to our full Promoting Health and Hygiene Policy (available on our website) for more information.
Government Funding. Neither the Company nor the Subsidiary has received or applied for any grant or other support or benefits (including, without limitation, tax benefits) from any Israeli or other government entity.
Government Funding. Otic Pharma is subject to the provisions of the Encouragement of Research, Development and Technological Innovation in the Industry Law 5744 1984, or the “Innovation Law” (formerly known as the Israeli Encouragement of Industrial Research and Development Law 5744-1984), as amended from time to time and/or such other law as will be legislated in lieu thereof, including the regulations, directives, procedures and rules that have been or will be promulgated thereunder and/or by virtue thereof. Section 3.26 of the Otic Pharma Disclosure Schedule provides a true, complete and correct list all pending and outstanding grants, incentives and subsidies from the Government of the State of Israel or any agency thereof, or from any Governmental Entity, granted to Otic Pharma and any of its Subsidiaries, including grants from the OCS (collectively, “Government Grants”). Otic Pharma has made available to Public Company true, complete and correct copies of all documents evidencing Government Grants submitted by Otic Pharma and any its Subsidiaries (or transferred or assigned or purchased by Otic Pharma and any of its Subsidiaries) and of all letters of approval, certificates of completion, and supplements and amendments thereto, granted to Otic Pharma and any of its Subsidiaries, and all material correspondence related thereto. Section 3.26 of the Otic Pharma Disclosure Schedule sets forth: (a) the aggregate amount of each Government Grant; (b) the aggregate outstanding obligations, if any, of Otic Pharma and each of its Subsidiaries under each Government Grant with respect to royalties or other payments; and (c) the outstanding amounts to be paid by the OCS to Otic Pharma and any of its Subsidiaries under the Government Grants, if any. Otic Pharma and each of its Subsidiaries are in compliance with the terms and conditions of all Government Grants and the laws applicable thereto (including the provisions of the Innovation Law and relevant regulations promulgated pursuant thereto), which have been approved, and have duly fulfilled all the undertakings required thereby to be fulfilled. To the knowledge of Otic Pharma, there is no event or other set of circumstances which would reasonably be expected to lead to the revocation or material modification of any of the Government Grants that have been approved. Otic Pharma represents that no OCS funded Intellectual Property is incorporated into Otic Pharma’s “Surfactant Platform” products, which are based on intellectual proper...
